World & BusinessJagsonpal Pharma signs deal to acquire Group Pharma’s wellness portfolio
The Economic Times reports an initial price of Rs 23.7 crore, plus an additional amount based on future sales.
TLDR
Jagsonpal Pharmaceuticals has signed a business transfer agreement to acquire Group Pharmaceuticals’ wellness portfolio, The Economic Times reports. The deal includes an initial consideration of Rs 23.7 crore plus an additional amount tied to future sales. The acquisition aims to expand Jagsonpal’s presence in women’s healthcare, while Group Pharma plans to focus its resources on oral care after the divestment.
Jagsonpal Pharma signs deal to acquire Group Pharma’s wellness portfolio
The Economic Times reports an initial price of Rs 23.7 crore, plus an additional amount based on future sales.
TLDR
Jagsonpal Pharmaceuticals has signed a business transfer agreement to acquire Group Pharmaceuticals’ wellness portfolio, The Economic Times reports. The deal includes an initial consideration of Rs 23.7 crore plus an additional amount tied to future sales. The acquisition aims to expand Jagsonpal’s presence in women’s healthcare, while Group Pharma plans to focus its resources on oral care after the divestment.